Roivant Sciences Ltd. NASDAQ:ROIVW

Financial Health
0
1
2
3
4
5
6
7
8
9

Roivant Sciences Ltd. stock price monthly change

-4.36%
month

Roivant Sciences Ltd. stock price quarterly change

-4.36%
quarter

Roivant Sciences Ltd. stock price yearly change

+91.97%
year

Roivant Sciences Ltd. key metrics

Market Cap
8.32B
Enterprise value
N/A
P/E
-0.34
EV/Sales
-1.47
EV/EBITDA
0.05
Price/Sales
22.82
Price/Book
1.03
PEG ratio
0.07
EPS
-1.26
Revenue
89.87M
EBITDA
-817.36M
Income
-902.38M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-2887.92%
Oper. margin
-2800.93%
Gross margin
78.18%
EBIT margin
-2800.93%
EBITDA margin
-909.5%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Roivant Sciences Ltd. stock price history

Roivant Sciences Ltd. stock forecast

Roivant Sciences Ltd. financial statements

Roivant Sciences Ltd. (NASDAQ:ROIVW): Profit margin
Dec 2021 24.34M -284.53M -1168.96%
Mar 2022 9.22M -291.31M -3158.55%
Mar 2023 27.37M -175.42M -640.79%
Mar 2024 28.93M -151.11M -522.35%
Roivant Sciences Ltd. (NASDAQ:ROIVW): Debt to assets
Sep 2022 2215534000 701.38M 31.66%
Dec 2022 2202960000 775.82M 35.22%
Mar 2023 2389604000 782.01M 32.73%
Mar 2024 7222482000 773.95M 10.72%
Roivant Sciences Ltd. (NASDAQ:ROIVW): Cash Flow
Dec 2021 -268.49M -6.07M -8.42M
Mar 2022 -147.46M -5.70M 1.07M
Mar 2023 -179.08M 113.55M 210.33M
Mar 2024 -108.45M 6.92M -32.62M

Roivant Sciences Ltd. alternative data

Roivant Sciences Ltd. (NASDAQ:ROIVW): Employee count
Aug 2023 620
Sep 2023 620
Oct 2023 620
Nov 2023 620
Dec 2023 620
Jan 2024 620
Feb 2024 620
Mar 2024 620
Apr 2024 620
May 2024 620
Jun 2024 620
Jul 2024 620

Roivant Sciences Ltd. other data

0.12% -1.80%
of ROIVW is owned by hedge funds
859.32K -12.55M
shares is hold by hedge funds

Roivant Sciences Ltd. (NASDAQ:ROIVW): Insider trades (number of shares)
Period Buy Sel
Mar 2022 0 357794
Apr 2022 40285 14319
May 2022 0 288339
Jun 2022 0 37892
Jul 2022 0 39037
Aug 2022 0 38191
Sep 2022 0 40186
Oct 2022 0 36786
Nov 2022 4000000 19578585
Dec 2022 0 168866
Jan 2023 0 119521
Feb 2023 0 4000000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
RAMASWAMY VIVEK director Common Shares 4,000,000 $7.95 $31,800,000
Sale
VENKER ERIC officer: President & COO
Common Shares 24,037 $8.02 $192,777
Sale
VENKER ERIC officer: President & COO
Common Shares 95,484 $7.32 $698,943
Sale
VENKER ERIC officer: President & COO
Common Shares 23,761 $8 $190,088
Sale
VENKER ERIC officer: President & COO
Common Shares 133,376 $7.03 $937,633
Sale
VENKER ERIC officer: President & COO
Common Shares 11,729 $7 $82,103
Purchase
DEXCEL PHARMA TECHNOLOGIES LTD. 10 percent owner
Common Shares 4,000,000 $5 $20,000,000
Sale
GOLD DANIEL ALLEN director
Common Shares 1,733,577 $4.75 $8,234,491
Sale
GOLD DANIEL ALLEN director
Common Shares 1,092,355 $4.75 $5,188,686
Sale
QVT FINANCIAL LP other
Common Shares 146,079 $4.75 $693,875
  • When is Roivant Sciences Ltd.'s next earnings date?

    Unfortunately, Roivant Sciences Ltd.'s (ROIVW) next earnings date is currently unknown.

  • Does Roivant Sciences Ltd. pay dividends?

    No, Roivant Sciences Ltd. does not pay dividends.

  • How much money does Roivant Sciences Ltd. make?

    Roivant Sciences Ltd. has a market capitalization of 8.32B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 125.73% to 124.8M US dollars.

  • What is Roivant Sciences Ltd.'s stock symbol?

    Roivant Sciences Ltd. is traded on the NASDAQ under the ticker symbol "ROIVW".

  • What is Roivant Sciences Ltd.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Roivant Sciences Ltd.?

    Shares of Roivant Sciences Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Roivant Sciences Ltd. have?

    As Jul 2024, Roivant Sciences Ltd. employs 620 workers.

  • When Roivant Sciences Ltd. went public?

    Roivant Sciences Ltd. is publicly traded company for more then 3 years since IPO on 27 Sep 2021.

  • What is Roivant Sciences Ltd.'s official website?

    The official website for Roivant Sciences Ltd. is roivant.com.

  • How can i contact Roivant Sciences Ltd.?

    Roivant Sciences Ltd. can be reached via phone at +44 4412955950.

Roivant Sciences Ltd. company profile:

Roivant Sciences Ltd.

roivant.com
Exchange:

NASDAQ

Full time employees:

620

Industry:

Biotechnology

Sector:

Healthcare

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

11-12 St. James’s Square
London, SW1Y 4LB

CIK: 0001635088
:
CUSIP: G76279119